SciBase hereby announces that the Annual report for 2017 is available at the Company’s website www.scibase.com.

The shareholders of SciBase Holding AB (publ), reg. no. 556773-4768, (hereinafter the “Company”) are hereby invited to the Annual General Meeting to be held on May 16, 2018 at 5.00 p.m. CET at Setterwalls Advokatbyrå’s  offices with address at Sturegatan 10 in Stockholm.

Outcome of the Offering

SciBase Holding AB (publ) (”SciBase” or the ”Company”) today announces that the secured new share issue with preferential rights for existing shareholders (the ”Offering”) has been completed and will provide the Company with approximately SEK 75 million before deduction of transaction costs. A total of approximately SEK 39.2 million, corresponding to 46.1 percent of the full Offering was subscribed for. Approximately SEK 36.6 million, corresponding to 43.0 percent of the Offering, was subscribed for by way of subscription rights and approximately SEK 2.5 million, corresponding to 3.0 percent of the Offering, was subscribed for  without exercise of subscription rights. The remaining part of the secured part of the Offering of SEK 75 million, corresponding to SEK 35.8 million or 42.0 percent of the total Offering amount of SEK 85 million, was allocated to guarantors. 

SciBase has received the first order from a customer as a result of their co-operation with the German medical technology company DermoScan. The order comes from a clinic in Munich that is a user of a DermoScan digital dermoscopy system and who has now chosen to add Nevisense to its diagnostic process. 

SciBase publishes prospectus in connection with SciBase’s preferential rights issue, Nov 20, 2017 Welcome to subscribe at SciBase rights offering Read more